Elovl6 is a negative clinical predictor for liver cancer and knockdown of Elovl6 reduces murine liver cancer progression

por Su, Yu-Chu, Feng, Yin-Hsun, Wu, Hung-Tsung, Huang, Yao-Shen, Tung, Chao-Ling, Wu, Pensee, Chang, Chih-Jen, Shiau, Ai-Li, Wu, Chao-Liang
Publicado 2018

Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer

por Feng, Yin-Hsun, Su, Yu-Chu, Lin, Shuo-Fu, Lin, Pey-Ru, Wu, Chao-Liang, Tung, Chao-Ling, Li, Chien-Feng, Shieh, Gia-Shing, Shiau, Ai-Li
Publicado 2019